🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Albuterol (Salbutamol) MDI or nebules

Found 7 matching trials

A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)

PHASE4

This is a multicenter, randomized, double-blind, placebo-controlled, 2-peri...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-01-23

Trial ID

NCT02275052

Treatments Being Tested

UMEC/VI DPI Placebo DPI Albuterol/salbutamol MDI

A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

PHASE4

This is a multicenter, randomized, double-blind, parallel-group study to ev...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-09-30

Trial ID

NCT02257372

Treatments Being Tested

UMEC DPI Placebo DPI ICS/LABA medication Albuterol/salbutamol Metered Dose Inhaler (MDI)

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

PHASE2

Nemiralisib is being developed as an anti-inflammatory drug for the treatme...

Status

Terminated

Location

GSK Investigational Site

Start Date

2017-11-28

Trial ID

NCT03345407

Treatments Being Tested

Placebo ELLIPTA Nemiralisib ELLIPTA 50 µg Nemiralisib ELLIPTA 100 µg Nemiralisib ELLIPTA 250 µg Nemiralisib ELLIPTA 500 µg Nemiralisib ELLIPTA 750 µg Albuterol (Salbutamol) MDI or nebules Standard of care therapy

A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

PHASE3

This is a phase IIIa, randomised, double-blind, double-dummy, parallel grou...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-01-23

Trial ID

NCT02345161

Treatments Being Tested

Triple FF/UMEC/VI Placebo to match FF/UMEC/VI Budesonide/Formoterol Placebo to match Budesonide/Formoterol combination Albuterol/salbutamol

A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

PHASE4

COPD is a progressive disease characterized by increasing obstruction to ai...

Status

Completed

Location

GSK Investigational Site

Start Date

2018-03-29

Trial ID

NCT03474081

Treatments Being Tested

FF/UMEC/VI Tiotropium Albuterol/salbutamol Placebo to match FF/UMEC/VI Placebo to match tiotropium ELLIPTA inhaler HANDIHALER MDI

Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma

PHASE3

This is a multicentre, randomized, double-blind, double-dummy, active-contr...

Status

Completed

Location

GSK Investigational Site

Start Date

2012-11-12

Trial ID

NCT01687296

Treatments Being Tested

fluticasone propionate inhalation solution oral prednisone placebo inhalation solution placebo tablet salbutamol

Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium

PHASE3

This is a Phase IIIb multicentre, randomised, blinded, triple dummy, parall...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-10-15

Trial ID

NCT02257385

Treatments Being Tested

UMEC/VI UMEC/VI matching placebo Tiotropium Tiotropium matching placebo Indacaterol Indacaterol matching placebo Albuterol/salbutamol Metered Dose Inhaler (MDI)

Previous Next